PD-L1
Showing 9976 - 10000 of >10,000
Bowel Disease Trial in Japan (NPO-13: l-menthol)
Completed
- Bowel Disease
- NPO-13: l-menthol
-
Kitakyushu, Fukuoka, Japan
- +12 more
Aug 13, 2020
Immune Resistance Interrogation Study
Recruiting
- Cancer
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 7, 2022
Severe Mental Illness, Lifestyle Trial in Amersfoort (GOAL!)
Not yet recruiting
- Severe Mental Illness
- Lifestyle
- GOAL!
-
Amersfoort, Utrecht, NetherlandsGGz Centraal
Oct 31, 2022
Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma Trial in Worldwide (Eflornithine, Lomustine)
Active, not recruiting
- Anaplastic Astrocytoma
- Recurrent Anaplastic Astrocytoma
-
Birmingham, Alabama
- +78 more
Jan 19, 2022
Neuroendocrine Carcinoma of the Lung and Thymus Trial in Worldwide (Pasireotide LAR, Everolimus, Pasireotide LAR and Everolimus
Completed
- Neuroendocrine Carcinoma of the Lung and Thymus
- Pasireotide LAR
- +2 more
-
Aarhus, Denmark
- +35 more
Mar 8, 2021
Disposable Bronchoscopes for Research Bronchoalveolar Lavage
Completed
- Healthy
- Bronchoalveolar Lavage validation study
-
Liverpool, United KingdomRoyal Liverpool Hospital Clinical Research Facility
Jun 6, 2022
MDD Trial in Boston (GeneSight Psychotropic test, Canadian Network for Mood and Anxiety Treatment (CANMAT) Best Practice
Completed
- Major Depressive Disorder
- GeneSight Psychotropic test
- Canadian Network for Mood and Anxiety Treatment (CANMAT) Best Practice Guidelines
-
Boston, MassachusettsMassachusetts General Hospital
Apr 5, 2022
Metabolic Syndrome Trial in Charlottesville (Low Intensity Exercise + Metformin, High Intensity Exercise + Metformin, Low
Active, not recruiting
- Metabolic Syndrome
- Low Intensity Exercise + Metformin
- +3 more
-
Charlottesville, VirginiaUniversity of Virginia
Dec 6, 2022
Immunotherapy Trial in Xuzhou (CAR-T cell immunotherapy)
Recruiting
- Immunotherapy
- CAR-T cell immunotherapy
-
Xuzhou, Jiangsu, ChinaAffiliated Hospital of Xuzhou Medical University
Apr 26, 2022
Neonatal Anemia Trial in Iowa City (Epoetin Alpha, Biotinylated Red Blood Cells)
Completed
- Neonatal Anemia
- Epoetin Alpha
- Biotinylated Red Blood Cells
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Apr 28, 2021
Multiple Myeloma Trial in Japan, United States (JNJ-68284528)
Completed
- Multiple Myeloma
- JNJ-68284528
-
Phoenix, Arizona
- +20 more
Oct 5, 2022
CArdioversion of Short Duration Atrial Fibrillation
Unknown status
- Atrial Fibrillation
- +2 more
-
Quebec City, Canada
- +2 more
Apr 16, 2020
Hepatocellular Carcinoma, Portal Vein Occlusion, Tumor Thrombus Trial in Guangzhou (TACE combined with iodine-125 seeds
Active, not recruiting
- Hepatocellular Carcinoma
- +2 more
- TACE combined with iodine-125 seeds implantation
- TACE
-
Guangzhou, Guangdong, ChinaThe 2nd Affiliated Hospital of Guangzhou Medical University
Mar 2, 2022
Duration of Treatment and Response in Multiple Myeloma or
Recruiting
- Multiple Myeloma
- Immunoglobulin Light-chain Amyloidosis
-
Cadiz, Andalucia, Spain
- +13 more
Dec 21, 2021
Motor Network Physiology
Recruiting
- Parkinson Disease
- Essential Tremor
- Inbrija
- Subcortical Stimulation
-
Dallas, TexasUT Southwestern Medical Center
Feb 28, 2022
Periodontal Bone Loss, Periodontal Diseases Trial in Cairo (L-PRF, OFD, CM)
Completed
- Periodontal Bone Loss
- Periodontal Diseases
- L-PRF
- +2 more
-
Cairo, EgyptAinshams University
Aug 11, 2022
Liver Carcinoma, Liver Transplant; Complications Trial in Shanghai (Durvalumab Injection, Lenvatinib 4 MG)
Recruiting
- Liver Carcinoma
- Liver Transplant; Complications
- Durvalumab Injection
- Lenvatinib 4 MG
-
Shanghai, ChinaRen Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Sep 19, 2020
Crohn's Disease Trial in Worldwide (PF-00547659 SC injection)
Completed
- Crohn's Disease
- PF-00547659 SC injection
-
Jonesboro, Arkansas
- +136 more
May 11, 2021
Locally Advanced Unresectable Gastric Cancer Trial in Guangzhou (Pemigatinib)
Not yet recruiting
- Locally Advanced Unresectable Gastric Cancer
-
Guangzhou, Guangdong, ChinaCancer center of SunYat-sen University
Aug 11, 2023
Rheumatoid Arthritis Trial in France, Monaco (infliximab, etanercept, adalimumab, abatacept, rituximab or tocilizumab)
Completed
- Rheumatoid Arthritis
- infliximab, etanercept, adalimumab
- abatacept, rituximab or tocilizumab
-
Amiens, France
- +43 more
Aug 5, 2021
Prostate Cancer Trial in Worldwide (Standard of Care)
Recruiting
- Prostate Cancer
- Standard of Care
-
Birmingham, Alabama
- +107 more
Aug 17, 2022
Anxiety Depression Trial (Mindfulness-based cognitive therapy using neuroscience (NMBCT))
Not yet recruiting
- Anxiety Depression
- Mindfulness-based cognitive therapy using neuroscience (NMBCT)
- (no location specified)
Jun 9, 2023
Ulcerative Colitis Trial in Worldwide (Mirikizumab, Placebo)
Active, not recruiting
- Ulcerative Colitis
- Mirikizumab SC
- +2 more
-
Dothan, Alabama
- +399 more
Nov 2, 2022